MENU
  • Our company
    • CEO message
    • Company profile
    • Mission
    • Origin of the company name
    • Corporate symbol and color
    • Team
  • Latest news
  • To investors
  • Contact
  • EnglishEnglish
    • 日本語日本語
    • EnglishEnglish
    • 中文 (中国)中文 (中国)

GEXVal

  • Our company
    • CEO message
    • Company profile
    • Mission
    • Origin of the company name
    • Corporate symbol and color
    • Team
  • Latest news
  • To investors
  • Contact
  • EnglishEnglish
    • 日本語日本語
    • EnglishEnglish
    • 中文 (中国)中文 (中国)

July 2019

  1. HOME
  2. July 2019
2019/7/1 / Last updated : 2019/11/28 wpmaster Latest news

EXVal Participates in “Venture Innovation Pavilion”

GEXVal Inc.July 1, 2019 GEXVal Participates in “Venture Innovation Pavilion” GEXVal will participate in the Ve […]

Recent posts

Article by GEXVal titled “Rare-disease Drugs via Drug Repositioning” published in Medical Science Digest

2019/11/28

GEXVal Featured in Nikkan Kogyo Shimbun

2019/9/19

GEXVal Featured in Nikkan Kogyo Shimbun

2019/9/10

GEXVal mentioned in Nikkan Kogyo Shimbun

2019/8/29

EXVal Participates in “Venture Innovation Pavilion”

2019/7/1

Scrip Interviews: GEXVal Focuses On Rare Diseases As It Builds On Ex-Takeda Assets

2019/6/4

GEXVal participates in CHINABIO PARTNERINGFURUM 2019

2019/4/26

GEXVal Appeared in Nikkei, Japan’s Largest Financial Paper

2019/4/22

GEXVal participated in the 139th Annual Meeting of the Pharmaceutical Society of Japan

2019/3/20

GEXVal gives presentation at BIO-Asia 2019

2019/1/19

Category

  • IR
  • Latest news

Archive

  • November 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • June 2018

Copyright © GEXValAll Rights Reserved.